Jefferies Initiates Coverage of MiniMed Group with Hold
Fintel reports that on October 12, 2026, Jefferies initiated coverage of MiniMed Group (NASDAQGS:MMED) (DB:B8S) with a Hold recommendation.
The initiation follows recent market activity where MiniMed Group's stock closed at $18.82 on October 12, 2026. This latest close represents a price change of -6.67% over the past week, compared to a baseline close of $20.16 on October 5, 2026. Over a one-month timeframe, the stock has experienced a price change of -16.38% from its baseline close of $22.50 on September 11, 2026. Prior to the rating action, the stock closed at $19.71 on October 9, 2026.
Separately from Jefferies' individual rating, the current consensus target mean for the stock was $26.52 as of October 2, 2026, representing an implied change of +40.95% from the market price at that time. The consensus target median stood at $27.03 on the same date. This current mean target is a revision of +1.06% from the prior consensus target mean of $26.24 recorded on September 15, 2026. In terms of broader analyst sentiment, the current recommendation period starting September 1, 2026, shows a total of 18 recommendations, consisting of 6 strong buy, 10 buy, and 2 hold ratings. This distribution reflects 88.9% positive recommendations and 11.1% hold recommendations.
MiniMed Group last reported earnings on September 1, 2026. The company reported an actual EPS of 0, compared to an estimate of 0.0952, which represents an EPS surprise of -100.00%. Actual revenue for the quarter was $843,000,000.00, compared to the estimated revenue of $843,606,708.00.
Other analysts have also recently adjusted or established their coverage on MiniMed Group. On October 8, 2026, Mizuho maintained its Outperform rating. Prior to that, on October 7, 2026, Barclays initiated coverage with an Equal-Weight rating. Additionally, Truist Securities initiated coverage on September 24, 2026, with a Buy rating.
Recent analyst actions
| Date | Analyst | Prior | Latest recommendation | Action |
|---|---|---|---|---|
| October 12, 2026 | Jefferies | Hold | initiated coverage | |
| October 8, 2026 | Mizuho | Outperform | Outperform | maintained |
| October 7, 2026 | Barclays | Equal-Weight | initiated coverage | |
| September 24, 2026 | Truist Securities | Buy | initiated coverage |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.